-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Repare Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2019 to Q2 2025.
- Repare Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2025 was $1.28M, a 55.3% decline year-over-year.
- Repare Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2025 was $7.23M, a 40.3% decline year-over-year.
- Repare Therapeutics Inc. annual Nonoperating Income (Expense) for 2024 was $10.3M, a 21.2% decline from 2023.
- Repare Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $13M, a 121% increase from 2022.
- Repare Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $5.9M, a 7868% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)